
Frederik Eisele
Articles
-
Jun 14, 2024 |
biorxiv.org | Frederik Eisele |Hyunsoo Park |Arash Chitsazan |Parisa Rabieifar
AbstractTargeted protein degradation (TPD) using bivalent proteolysis targeting chimeras (PROTAC) technology has shown potential in expanding the druggable proteome. In their publication in Nature Chemical Biology, Imaide et al.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →